Background: Optical coherence tomography (OCT) is an optical imaging technology with a potential in the non-invasive diagnosis of skin cancer. To identify skin pathologies using OCT, it is of prime importance to establish baseline morphological features of normal skin. Aims: The aim of this study is to describe normal skin morphology using OCT and polarization-sensitive OCT (PS-OCT), which is a way of representing birefringent tissue such as collagen in OCT images. Anatomical locations in 20 healthy volunteers were imaged, and epidermal thickness (ET) was measured and compared to age, gender and skin colour. Methods: OCT imaging is based on infrared light reflection/backscatter from tissue. PS-OCT detects birefringence of tissue. Imaging was performed in 12 skin regions. ET was calculated from the OCT images. Results: Normal skin has a layered structure. Layering is less pronounced in adults. In glabrous skin the stratum corneum is visible. Children had larger ET (p < 0.0001). Age had a negative correlation with ET (p < 0.05). No gender- or skin-type-related differences in ET were found. Conclusion: This study contributes to understanding OCT and PS-OCT images of normal skin and indicates that OCT can be used for both the qualitative and quantitative assessment of skin.

Keywords:
Optical coherence tomography, polarization-sensitive, Epidermal thickness, normal skin, Diagnostic imaging
1.
Gambichler T, Moussa G, Sand M, et al: Applications of optical coherence tomography in dermatology. J Dermatol Sci 2005;40:85–94.
2.
Marghoob AA, Swindle LD, Moricz CZ, et al: Instruments and new technologies for the in vivo diagnosis of melanoma. J Am Acad Dermatol 2003;49:777–797.
3.
Jemec GB, Gniadecka M, Ulrich J: Ultrasound in dermatology. I. High frequency ultrasound. Eur J Dermatol 2000;10:492–497.
4.
El Gammal S, El Gammal C, Altmeyer PJ, et al: High-resolution sonography of the skin; in Serup J, Jemec GBE, Grove GL (eds): Handbook of Non-Invasive Methods and the Skin, ed 2. Boca Raton, CRC Press, Taylor & Francis, 2006.
5.
Kittler H, Pehamberger H, Wolff K, et al: Diagnostic accuracy of dermoscopy. Lancet Oncol 2002;3:159–165.
6.
Zalaudek I: Dermoscopy subpatterns of nonpigmented skin tumors. Arch Dermatol 2005;141:532.
7.
Gerger A, Koller S, Weger W, et al: Sensitivity and specificity of confocal laser-scanning microscopy for in vivo diagnosis of malignant skin tumors. Cancer 2006;107:193–200.
8.
Liffers A, Vogt M, Ermert H: In vivo biomicroscopy of the skin with high-resolution magnetic resonance imaging and high frequency ultrasound. Biomed Tech (Berl) 2003;48:130–134.
9.
Theumann NH, Goettmann S, Le VD, et al: Recurrent glomus tumors of fingertips: MR imaging evaluation. Radiology 2002;223:143–151.
10.
Lin SJ, Jee SH, Kuo CJ, et al: Discrimination of basal cell carcinoma from normal dermal stroma by quantitative multiphoton imaging. Opt Lett 2006;31:2756–2758.
11.
Woodward RM, Cole BE, Wallace VP, et al: Terahertz pulse imaging in reflection geometry of human skin cancer and skin tissue. Phys Med Biol 2002;47:3853–3863.
12.
Olmedo JM, Warschaw KE, Schmitt JM, et al: Optical coherence tomography for the characterization of basal cell carcinoma in vivo: a pilot study. J Am Acad Dermatol 2006;55:408–412.
13.
Pierce MC, Strasswimmer J, Park BH, et al: Advances in optical coherence tomography imaging for dermatology. J Invest Dermatol 2004;123:458–463.
14.
Welzel J: Optical coherence tomography in dermatology: a review. Skin Res Technol 2001;7:1–9.
15.
Gluud C, Gluud LL: Evidence based diagnostics. BMJ 2005;330:724–726.
16.
Welzel J, Reinhardt C, Lankenau E, et al: Changes in function and morphology of normal human skin: evaluation using optical coherence tomography. Br J Dermatol 2004;150:220–225.
17.
Gambichler T, Matip R, Moussa G, et al: In vivo data of epidermal thickness evaluated by optical coherence tomography: effects of age, gender, skin type, and anatomic site. J Dermatol Sci 2006;44:145–152.
18.
Fruhstorfer H, Abel U, Garthe CD, et al: Thickness of the stratum corneum of the volar fingertips. Clin Anat 2000;13:429–433.
19.
Neerken S, Lucassen GW, Bisschop MA, et al: Characterization of age-related effects in human skin: a comparative study that applies confocal laser scanning microscopy and optical coherence tomography. J Biomed Opt 2004;9:274–281.
20.
Gambichler T, Moussa G, Regeniter P, et al: Validation of optical coherence tomography in vivo using cryostat histology. Phys Med Biol 2007;52:N75–N85.
21.
Sandby-Moller J, Poulsen T, Wulf HC: Epidermal thickness at different body sites: relationship to age, gender, pigmentation, blood content, skin type and smoking habits. Acta Derm Venereol 2003;83:410–413.
22.
Olmedo JM, Warschaw KE, Schmitt JM, et al: Correlation of thickness of basal cell carcinoma by optical coherence tomography in vivo and routine histologic findings: a pilot study. Dermatol Surg 2007;33:421–425.
23.
Gambichler T, Boms S, Stucker M, et al: Acute skin alterations following ultraviolet radiation investigated by optical coherence tomography and histology. Arch Dermatol Res 2005;297:218–225.
24.
Gambichler T, Orlikov A, Vasa R, et al: In vivo optical coherence tomography of basal cell carcinoma. J Dermatol Sci 2007;45:167–173.
25.
Strasswimmer J, Pierce MC, Park BH, et al: Polarization-sensitive optical coherence tomography of invasive basal cell carcinoma. J Biomed Opt 2004;9:292–298.
26.
Barton JK, Gossage KW, Xu W, et al: Investigating sun-damaged skin and actinic keratosis with optical coherence tomography: a pilot study. Technol Cancer Res Treat 2003;2:525–535.
27.
Gambichler T, Hyun J, Moussa G, et al: Optical coherence tomography of cutaneous lupus erythematosus correlates with histopathology. Lupus 2007;16:35–38.
28.
Gambichler T, Moussa G, Sand M, et al: Correlation between clinical scoring of allergic patch test reactions and optical coherence tomography. J Biomed Opt 2005;10:064030.
29.
Welzel J, Bruhns M, Wolff HH: Optical coherence tomography in contact dermatitis and psoriasis. Arch Dermatol Res 2003;295:50–55.
30.
Morsy H, Mogensen M, Thrane L, Jemec GBE: Imaging of intradermal tattoos by optical coherence tomography. Skin Res Technol 2007;13:444–448.
31.
Welzel J, Lankenau E, Birngruber R, et al: Optical coherence tomography of the skin. Curr Probl Dermatol 1998;26:27–37.
32.
Morsy H, Mogensen M, Thomsen J, et al: Imaging of cutaneous larva migrans by optical coherence tomography. Travel Med Infect Dis 2007;5:243–246.
33.
Gambichler T, Boms S, Stucker M, et al: Comparison of histometric data obtained by optical coherence tomography and routine histology. J Biomed Opt 2005;10:44008.
34.
Tycho A, Andersen P, Thrane L, et al: Optical coherence tomography in dermatology; in Serup J, Jemec GBE, Grove GL (eds): Handbook of Non-Invasive Methods and the Skin, ed 2. Boca Raton, CRC Press, Taylor & Francis, 2006.
35.
Fujimoto JG: Optical coherence tomography for ultrahigh resolution in vivo imaging. Nat Biotechnol 2003;21:1361–1367.
36.
Gladkova ND, Petrova GA, Nikulin NK, et al: In vivo optical coherence tomography imaging of human skin: norm and pathology. Skin Res Technol 2000;6:6–16.
37.
Strasswimmer J, Pierce MC, Park B, et al: Characterization of basal cell carcinoma by multifunctional optical coherence tomography. J Invest Dermatol 2003;121:0156.
38.
Takiwaki H: Measurement of skin color: practical application and theoretical considerations. J Med Invest 1998;44:121–126.
39.
Ya-Xian Z, Suetake T, Tagami H: Number of cell layers of the stratum corneum in normal skin – relationship to the anatomical location on the body, age, sex and physical parameters. Arch Dermatol Res 1999;291:555–559.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.